Express Scripts (ESRX) is buying its larger competitor Medco Health Solutions (MHS).  Express Scripts  is a pharmacy benefit manager.  The Wall Street likes the deal and currently Express Scripts is up over $3.00. 

Our analysis shows that there may be serious anti trust issues here that the Wall Street has not thought about.  Normally we would have given a signal right here, but our long experience with trading Express Scripts stock shows that there is a propensity for a short squeeze.  We will not short here, but will watch Express Scripts for a short squeeze.  If a short squeeze occurs, we will short this stock at the end of the short squeeze. 

An actionable signal will be provided  in real-time on the Real Time Feed of the ZYX Short Sell Change Alert.